Allergy Thera. Share News (AGY)

LONDON (Alliance News) - The following is a summary of director dealings reported in London on Monday.
----------
MySale Group said its newly appointed Chairman Iain McDonald bought 60,000 shares at a price of 44.91483 pence per share Monday.

After the purchase he holds 148,482 shares, representing approximately 0.10% of the issued share capital.

The online flash sale retailer earlier Monday said it is set to post higher revenue for the year to the end of June and said its performance improved in the second half. MySale said its revenue for the year was up by 5% to AUD235 million and said its second-half underlying earnings before interest, taxation, depreciation and amortisation should be broadly break-even.

In addition to the trading update, the company said it had appointed McDonald as its new non-executive chairman. He is a partner at William Currie Group, the technology and e-commerce investment company.

"MySale is focussed on profitable growth and we are pleased with the progress achieved over the last six months. We are delighted that Iain McDonald has joined as chairman bringing a wealth of online retail and significant UK capital markets experience," said Carl Jackson, MySale's chief executive.

The stock closed up 10% at 43.96p on Monday, having hit a high for the year of 46.00p earlier in the day.
----------
Range Resources said it has been informed that all of the necessary government and regulatory approvals have been received which will allow the company to secure its funding package from Beijing Sibo Investment Management.

The last hurdle is gaining approval from Range shareholders at the extraordinary general meeting which will be held in August, with a firm date to be declared before the end of July. Shareholders will also vote on a related subscription by the directors of the company.

In early June, Range received the first tranche of funding, totalling GBP5.2 million, resulting in Range issuing 650 million new shares to Beijing Sibo at the subscription price of GBP0.008 per share, giving it an 11.5% stake in Range. Shareholder approval was not needed for that first tranche. Under the second tranche, Sibo will subscribe to further shares at the same price as the first tranche, to total a USD22.1 million investment. However the company said the final amount will be confirmed after the EGM.

Following the second tranche, Range will have secured USD30 million from the deal, with a further USD300,000 set to be received from its directors who have agreed to subscribe to shares at the same subscription price.

The directors investing are Chairman David Chen who is investing USD96,000, Executive Director Yan Liu with USD76,000 and Non Executive Directors Zhiwei Gu and Juan Wang who will invest USD25,000 each.

Shares closed down 0.3% at 0.623p Monday.
----------
Allergy Therapeutics said Chief Executive Officer Manuel Llobet bought 50,000 shares at a price of 24.45 pence per share Friday. Following this transaction, Llobet's beneficial holding now stands at 3.2 million shares, which represents 0.58% of the issued share capital. The purchase came after Allergy Therapeutics on Thursday said it expects to post revenue growth of 11% for its recently ended financial year at constant currency, although its reported figures will be hit the weakening of the euro. Shares in the research and development company closed up 3.3% at 25.5p Monday.
----------
Unilever said Chief Marketing and Communication Officer Keith Weed sold 2,650 shares at a price of 2,899.9671 pence per share Monday. A person connected to Weed, Catherine Weed, also sold 3,700 share in the company at a price of 2,903.77 pence last Friday. Shares in the company closed down 1.4% at 2,858.81 pence Monday.
----------
Publishing Technology said Chief Executive Officer Michael Cairns bought 65,000 shares at a price of 133 pence per share on Friday. Cairns' beneficial interest in the company now is 95,400 shares, representing approximately 0.58% of its issued share capital. Shares in the content solutions provider closed down 0.6% at 126.75p Monday.
----------
Lowland Investment Co said Non-Executive Director Kevin Carter bought 3,000 shares at a price of 1,373.60 pence per share on Monday. Following this transaction, Carter holds 8,000 shares, which represents 0.02% stake in the trust. The stock closed down 0.8% at 1,370.50p Monday.
----------
Murray International said Chairman of the Board of the Manager Kevin Carter bought 5,000 shares at a price of 900.46 pence per share on Monday. Following this transaction, Carter holds 30,000 shares, which represents a 0.02% stake in the trust. The stock closed down 0.2% at 902.00p Monday.
----------
JPMorgan Emerging Markets Investment Trust said Non-Executive Director Andrew Page bought 5,000 shares at a price of 578.37 pence per share Monday. The purchase is his only holding in the company after being appointed in December 2014. The stock closed down 1.7% at 573.50p Monday.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.